BCMA CAR-T therapy as salvage therapy in patients with plasmablastic myeloma

Objectives: Plasmablastic myeloma (PBM) is a variant of multiple myeloma associated with a poor prognosis. We investigated the efficacy and safety of B-cell maturation antigen (BCMA) chimeric antigen receptor T cell (CAR-T) therapy in patients with PBM.Methods: The study comprised six patients diagn...

Full description

Bibliographic Details

Published in:	Hematology
Main Authors:	Chengwei Jin, Jing Deng, Ying Jiang, Jun Zhu, Liqing Kang, Su Li
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2025-12-01
Subjects:	Plasmablastic myeloma BCMA CAR-T CD19 CAR-T ASCT
Online Access:	https://www.tandfonline.com/doi/10.1080/16078454.2025.2481555